Lv3
288 积分 2024-08-18 加入
Glucose-dependent insulinotropic peptide and beyond: co-agonist innovations in the treatment of metabolic diseases
12天前
已关闭
Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
17天前
已完结
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
2个月前
已完结
GLP-1/GIP/glucagon receptor triagonism gets its try in humans
2个月前
已完结
Phase I results for AMG 133
2个月前
已完结
Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease
2个月前
已完结
Glucose-dependent insulinotropic polypeptide receptor knockout mice are impaired in learning, synaptic plasticity, and neurogenesis
2个月前
已完结
New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer’s disease?
2个月前
已完结
Protease-Resistant Glucose-Dependent Insulinotropic Polypeptide Agonists Facilitate Hippocampal LTP and Reverse the Impairment of LTP Induced by Beta-Amyloid
2个月前
已完结
Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures
2个月前
已完结
皖公网安备34019202002308
